Chromatography
Peptide Sample Analysis Using EternityXT
Mar 16 2018
The peptide therapeutic market continues to develop fast where pharmaceutical companies focus in these types of compounds for large number of diseases. Chromatography plays an important role across the entire drug development cycle. Kromasil EternityXT, chemically stable merged inorganic/organic silica material for reversed phase chromatography, is a perfect material to be used from analysis to scale up of peptides.
With excellent mechanical and chemical stability, the Kromasil EternityXT materials offer first-rate separation power as well as loadability at low, medium and high pH. EternityXT columns are provided in 1.8 µm particles for UHPLC, 2.5 µm particles for both UHPLC and HPLC applications and finally 5 µm particles for HPLC and semipreparative chromatography. The C18 and C8 chemistries are also available in bulk for purification. The Kromasil EternityXT columns are based on patented technology, resulting from 30 years of expertise and used by chromatographers worldwide.
Digital Edition
Lab Asia 31.2 April 2024
April 2024
In This Edition Chromatography Articles - Approaches to troubleshooting an SPE method for the analysis of oligonucleotides (pt i) - High-precision liquid flow processes demand full fluidic c...
View all digital editions
Events
Apr 25 2024 Istanbul, Turkey
Apr 28 2024 Montreal, Quebec, Canada
May 05 2024 Seville, Spain
InformEx Zone at CPhl North America
May 07 2024 Pennsylvania, PA, USA
May 14 2024 Oklahoma City, OK, USA